Collegium Pharmaceutical
(NASDAQ) COLL
Collegium Pharmaceutical Financials at a Glance
Market Cap
$1.03B
Revenue (TTM)
$780.57M
Net Income (TTM)
$62.87M
EPS (TTM)
$1.72
P/E Ratio
18.82
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$32.27
Volume
28,274
Open
$32.97
Price
$32.27
Volume
28,274
Open
$32.97
Previous Close
$32.27
Daily Range
$32.11 - $33.36
52-Week Range
$23.23 - $50.79
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$32.27
Volume
28,274
Open
$32.97
Previous Close
$32.27
Daily Range
$32.11 - $33.36
52-Week Range
$23.23 - $50.79
COLL News
COLL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Collegium Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
423
CEO
Vikram Karnani, MBA
Website
www.collegiumpharma.comHeadquarters
Stoughton, MA 02072, US
COLL Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
23%
Net Income Margin
8%
Return on Equity
24%
Return on Capital
15%
Return on Assets
4%
Earnings Yield
5.31%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.03B
Shares Outstanding
31.75M
Volume
28.27K
Short Interest
0.00%
Avg. Volume
515.60K
Financials (TTM)
Gross Profit
$463.26M
Operating Income
$187.08M
EBITDA
$401.00M
Operating Cash Flow
$329.32M
Capital Expenditure
$1.74M
Free Cash Flow
$327.58M
Cash & ST Invst.
$406.53M
Total Debt
$940.56M
Collegium Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$205.45M
+12.9%
Gross Profit
$128.38M
+30.6%
Gross Margin
62.49%
N/A
Market Cap
$1.03B
N/A
Market Cap/Employee
$2.87M
N/A
Employees
357
N/A
Net Income
$16.96M
+35.3%
EBITDA
$303.57M
+214.8%
Quarterly Fundamentals
Net Cash
$534.03M
+23.3%
Accounts Receivable
$211.33M
-7.5%
Inventory
$40.91M
+15.1%
Long Term Debt
$910.15M
+14.7%
Short Term Debt
$30.41M
-53.8%
Return on Assets
3.79%
N/A
Return on Invested Capital
14.76%
N/A
Free Cash Flow
$122.36M
+45.5%
Operating Cash Flow
$123.05M
+45.4%